Size-Exclusion Chromatography–Mass Spectrometry Analysis of mAbs on a Biocompatible Flow Path
(Neil Rees, VP and head of Agilent's ESG programs, explains how ESG is woven into our business)
(Mike McMullen discusses setting the pace for strong growth.)
Radiation oncologist recognized for breakthroughs in analyzing living cells
iLab capability helps users implement social distancing in laboratories